These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2899718)

  • 1. Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism.
    Goldhaber SZ; Kessler CM; Heit J; Markis J; Sharma GV; Dawley D; Nagel JS; Meyerovitz M; Kim D; Vaughan DE
    Lancet; 1988 Aug; 2(8606):293-8. PubMed ID: 2899718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial.
    Goldhaber SZ; Kessler CM; Heit JA; Elliott CG; Friedenberg WR; Heiselman DE; Wilson DB; Parker JA; Bennett D; Feldstein ML
    J Am Coll Cardiol; 1992 Jul; 20(1):24-30. PubMed ID: 1607532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolytic therapy of acute pulmonary embolism: current status and future potential.
    Goldhaber SZ; Meyerovitz MF; Markis JE; Kim D; Kessler CM; Sharma GV; Vaughan DE; Selwyn AP; Dawley DL; Loscalzo J
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):96B-104B. PubMed ID: 3117862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute pulmonary embolism treated with tissue plasminogen activator.
    Goldhaber SZ; Vaughan DE; Markis JE; Selwyn AP; Meyerovitz MF; Loscalzo J; Kim DS; Kessler CM; Dawley DL; Sharma GV
    Lancet; 1986 Oct; 2(8512):886-9. PubMed ID: 2876327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue plasminogen activator in acute pulmonary embolism.
    Goldhaber SZ
    Chest; 1989 May; 95(5 Suppl):282S-289S. PubMed ID: 2495913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravenous infusion of recombinant tissue-type plasminogen activator (rt-PA) and urokinase in acute myocardial infarct: intermediate results of the G.A.U.S. study (German Activator Urokinase Study)].
    Neuhaus KL; Tebbe U; Gottwik M; Weber MA; Feuerer W; Niederer W; Haerer W; Praetorius F; Grosser KD; Huhmann W
    Klin Wochenschr; 1988; 66 Suppl 12():102-8. PubMed ID: 3126339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism Group.
    Goldhaber SZ; Agnelli G; Levine MN
    Chest; 1994 Sep; 106(3):718-24. PubMed ID: 8082347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial.
    Meyerovitz MF; Goldhaber SZ; Reagan K; Polak JF; Kandarpa K; Grassi CJ; Donovan BC; Bettmann MA; Harrington DP
    Radiology; 1990 Apr; 175(1):75-8. PubMed ID: 2107563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue plasminogen activator and acute pulmonary embolism.
    Goldhaber SZ; Kessler CM; Heit J; Markis JE; Sharma GV; Dawley DL; Meyerovitz MF; Vaughan DE; Parker JA; Come PC
    J Cell Biochem; 1988 Dec; 38(4):303-12. PubMed ID: 3149283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue plasminogen activator for the treatment of acute pulmonary embolism. A collaborative study by the PIOPED Investigators.
    Chest; 1990 Mar; 97(3):528-33. PubMed ID: 2106408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a European multicenter double-blind trial. The European Cooperative Study Group for Pulmonary Embolism.
    Meyer G; Sors H; Charbonnier B; Kasper W; Bassand JP; Kerr IH; Lesaffre E; Vanhove P; Verstraete M
    J Am Coll Cardiol; 1992 Feb; 19(2):239-45. PubMed ID: 1732347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary perfusion after rt-PA therapy for acute embolism: early improvement assessed with segmental perfusion scanning.
    Parker JA; Markis JE; Palla A; Goldhaber SZ; Royal HD; Tumeh S; Kim D; Rustgi AK; Holman BL; Kolodny GM
    Radiology; 1988 Feb; 166(2):441-5. PubMed ID: 3122266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urokinase versus tissue plasminogen activator in pulmonary embolism.
    Goldhaber SZ; Loscalzo J
    Lancet; 1988 Oct; 2(8616):915. PubMed ID: 2902375
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombolysis in venous thromboembolism. An international perspective.
    Goldhaber SZ
    Chest; 1990 Apr; 97(4 Suppl):176S-181S. PubMed ID: 2108856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism.
    Levine M; Hirsh J; Weitz J; Cruickshank M; Neemeh J; Turpie AG; Gent M
    Chest; 1990 Dec; 98(6):1473-9. PubMed ID: 2123152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion.
    Goldhaber SZ; Haire WD; Feldstein ML; Miller M; Toltzis R; Smith JL; Taveira da Silva AM; Come PC; Lee RT; Parker JA
    Lancet; 1993 Feb; 341(8844):507-11. PubMed ID: 8094768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of treatment regimens in 58 cases with acute pulmonary embolism].
    Liang Y; Yang J; Liu S
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Apr; 23(4):235-8. PubMed ID: 11778213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of limited-dose tissue plasminogen activator in acute vascular occlusion.
    Shortell CK; Queiroz R; Johansson M; Waldman D; Illig KA; Ouriel K; Green RM
    J Vasc Surg; 2001 Nov; 34(5):854-9. PubMed ID: 11700486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of acute pulmonary embolism with urokinase compared with the combination plasminogen-urokinase. Apropos of 67 cases].
    François G; Charbonnier B; Raynaud P; Garnier LF; Griguer P; Brochier M
    Arch Mal Coeur Vaiss; 1986 Apr; 79(4):435-42. PubMed ID: 3090961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant tissue plasminogen activator in patients with pulmonary embolism: correlation of fibrinolytic specificity and efficacy.
    Vaughan DE; Goldhaber SZ; Kim J; Loscalzo J
    Circulation; 1987 Jun; 75(6):1200-3. PubMed ID: 3105914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.